HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brian M Ross Selected Research

methyl nicotinate

1/2018Methylnicotinate stimulated prostaglandin synthesis in patients with schizophrenia: A preliminary investigation.
10/2004Delayed vasodilatory response to methylnicotinate in patients with unipolar depressive disorder.
5/2004Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry.
10/2003Methyl nicotinate-induced vasodilation in generalized social phobia.
9/2003On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brian M Ross Research Topics

Disease

9Schizophrenia (Dementia Praecox)
01/2018 - 09/2003
3Bipolar Disorder (Manic Depressive Psychosis)
03/2011 - 09/2003
3Mental Disorders (Mental Disorder)
09/2007 - 09/2003
2Erythema
01/2018 - 10/2004
2Anxiety Disorders (Anxiety Disorder)
11/2016 - 11/2009
2Major Depressive Disorder (Major Depressive Disorders)
11/2009 - 01/2007
2Mood Disorders (Mood Disorder)
09/2007 - 06/2006
2Lymphoma (Lymphomas)
02/2007 - 08/2005
2Psychotic Disorders (Schizoaffective Disorder)
06/2006 - 09/2003
1Cardiovascular Diseases (Cardiovascular Disease)
11/2015
1Neoplasms (Cancer)
11/2015
1Periodontal Diseases (Periodontal Disease)
07/2011
1Depressive Disorder (Melancholia)
10/2004
1Chronic Disease (Chronic Diseases)
05/2004
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
10/2003
1Social Phobia
10/2003
1Flushing
09/2003
1Catalepsy
08/2002

Drug/Important Bio-Agent (IBA)

6Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2016 - 10/2003
5methyl nicotinateIBA
01/2018 - 09/2003
4Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2009 - 10/2003
4Phospholipids (Phosphatides)FDA LinkGeneric
01/2007 - 12/2003
3EthaneIBA
03/2011 - 10/2003
3Fatty Acids (Saturated Fatty Acids)IBA
09/2007 - 09/2003
2Biomarkers (Surrogate Marker)IBA
11/2015 - 04/2008
2Docosahexaenoic AcidsIBA
09/2007 - 08/2005
2Eicosapentaenoic AcidIBA
09/2007 - 02/2007
2AntioxidantsIBA
02/2007 - 10/2003
2Oxidants (Oxidizing Agents)IBA
02/2007 - 08/2005
2Arachidonic Acid (Vitamin F)IBA
02/2007 - 08/2005
1ProstaglandinsIBA
01/2018
1AldehydesIBA
11/2015
1AlkanesIBA
03/2011
1butaneIBA
03/2011
1Anti-Anxiety Agents (Anxiolytics)IBA
11/2009
1Free RadicalsIBA
04/2008
1Calcium-Independent Phospholipases A2IBA
06/2006
1CalciumIBA
06/2006
1DNA (Deoxyribonucleic Acid)IBA
06/2006
1EnzymesIBA
06/2006
1EicosanoidsIBA
12/2003
1Niacin (Nicotinic Acid)FDA LinkGeneric
12/2003
1LipidsIBA
10/2003
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
09/2003
1Dopamine Agents (Dopaminergic Agents)IBA
08/2002
1Cyclooxygenase InhibitorsIBA
08/2002
1Dopamine (Intropin)FDA LinkGeneric
08/2002
1Haloperidol (Haldol)FDA LinkGeneric
08/2002
1RacloprideIBA
08/2002
1SCH 23390IBA
08/2002

Therapy/Procedure

2Therapeutics
09/2007 - 10/2003
1Oral Hygiene (Dental Hygiene)
07/2011
1Lasers (Laser)
05/2004